Comparison of percutaneous coronary intervention versus medication in dialysis patients with coronary artery disease

Back

ESC Professional Premium Access

Comparison of percutaneous coronary intervention versus medication in dialysis patients with coronary artery disease

Session: Renal failure and bleeding in PCI patients

Topic: Outcome

Speaker: Doctor E. Xie (Beijing, CN)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Enmin Xie

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

0 follower

4 more presentations in this session

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events.

Speaker: Doctor S. Ikebe (Kumamoto, JP)

High bleeding risk mainly predicts non-access site bleeding events in the first month after percutaneous coronary intervention

Speaker: Ms E. Woelders (Nijmegen, NL)

Parsimonious versus extensive score: can we simplify bleeding risk stratification after percutaneous coronary intervention without losing specificity?

Speaker: Ms E. Woelders (Nijmegen, NL)

Platelet reactivity and activated clotting time predict haemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary intervention

Speaker: Doctor B. Ramotowski (Warsaw, PL)

Access the full session

Renal failure and bleeding in PCI patients

Speakers: Doctor E. Xie, Doctor S. Ikebe, Ms E. Woelders, Ms E. Woelders, Doctor B. Ramotowski

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources